-+ 0.00%
-+ 0.00%
-+ 0.00%

Acadia Pharmaceuticals announces virtual annual shareholder meeting

PUBT·04/28/2026 19:13:29
Listen to the news
Acadia Pharmaceuticals announces virtual annual shareholder meeting
  • Acadia Pharmaceuticals will hold its 2026 annual stockholders meeting in virtual format on May 29, 2026.
  • Stockholders will vote on election of three Class I directors to serve terms running through 2029.
  • Advisory vote scheduled on named executive officer compensation.
  • Ernst & Young set for stockholder ratification as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.
  • Proposal includes amendment to 2024 Equity Incentive Plan to add 5,209,670 shares for issuance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ACADIA Pharmaceuticals Inc. published the original content used to generate this news brief on April 28, 2026, and is solely responsible for the information contained therein.